BioMed Research International / 2014 / Article / Tab 2

Clinical Study

Partial Splenic Embolization with Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma Accompanied by Thrombocytopenia

Table 2

Changes of the laboratory data between before treatment and 1 month after partial splenic embolization with transarterial chemoembolization.

PretreatmentAfter 1 weekAfter 1 month
DataDataMean of difference valueDataMean of difference value

Platelet counts (/mm3)0.9 (−0.1 to 2.0)0.0834.9 (3.2 to 6.7)<0.001
Hemoglobin (g/dL)−0.7 (−1.2 to 0.2)0.012−0.5 (−1.0 to −0.0)0.046
Neutrocyte counts (/mm3)1,4,,7972,241 (1,016 to 3,047)0.0012,56,055687 (408 to 965)<0.001
Total bilirubin (mg/dL)0.2 (0.0 to 0.5)0.063−0.2 (−0.4 to 0.0)0.039
Albumin (g/dL)−0.4 (−0.6 to −0.3)<0.001−0.1 (−0.3 to 0.0)0.036
PT-INR0.03 (−0.01 to 0.07)0.123−0.04 (−0.08 to 0.01)0.092
Child-Pugh score0.5 (0.1 to 0.9)0.0210.1 (−0.3 to 0.4)0.748

PT-INR, prothrombin time-international normalized ratio.